For the Inventor, By the Inventor

Enter assignee name

San Carlos, CA, United States of America

Biocardia, Inc.

USPTO Granted Patents = 57

% Expired Patents = 8.8

EPO Patents = 7

Trademarks = 3

Forward Citations = 4,674

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Peter A Altman (48 out of 62 patents)

Daniel C Rosenman (18 out of 38 patents)

Simon H Stertzer (11 out of 11 patents)

4. Daniel Jordan Kayser (10 out of 12 patents)

5. Wai Hsueh (7 out of 7 patents)

6. Ken Vien (7 out of 7 patents)

7. James B Ross (7 out of 13 patents)

8. Julio Argentieri (7 out of 7 patents)

9. Michael Keleher (6 out of 6 patents)

10. Nick Fravala (6 out of 6 patents)

11. Richard Cook (6 out of 6 patents)

12. Mark Tale (6 out of 6 patents)

13. Frank Arko (6 out of 6 patents)

14. Aaron J Miller (5 out of 12 patents)

15. John D Altman (5 out of 8 patents)

Core Competencies:

Steerable Catheters

Drug Delivery Catheters

Cardiac Treatments

Myocardial Infarction

Therapeutic Potency

Image Annotation

Autologous Cell Therapies

Endoluminal Devices

Vascular Access

Implant Delivery Systems

Pulmonary Vein Diagnostics

Bio-Interventional Treatments

57 patents: Sort by Forward Citations

1. 12311127 - Radial and trans-endocardial delivery catheter (2025-05-27),

2. 12036371 - Method of accessing the left atrium with a multi-directional steerable catheter (2024-07-16),

3. 11986611 - Radial and trans-endocardial delivery catheter (2024-05-21),

4. 11828757 - Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies (2023-11-28),

5. 11642377 - Bone marrow derived neurokinin-1 receptor positive (NK1R+) mesenchymal stem cells for therapeutic applications (2023-05-09),

6. 11617859 - Multi-directional steerable catheter (2023-04-04),

7. 11357463 - Target site selection, entry and update with automatic remote image annotation (2022-06-14),

8. 11141568 - Multi-directional steerable catheter (2021-10-12),

9. 10874831 - Devices and methods for accessing the vasculature of a patient (2020-12-29),

10. 10780248 - Radial and trans-endocardial delivery catheter (2020-09-22),

11. 10632281 - Drug delivery catheters that attach to tissue and methods for their use (2020-04-28),

12. 10520505 - Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies (2019-12-31),

13. 10071226 - Radial and trans-endocardial delivery catheter (2018-09-11),

14. 10035982 - Method of preparing autologous cells and methods of use for therapy (2018-07-31),

15. 9945854 - Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies (2018-04-17),

Company Overview

Biocardia, Inc., based in San Carlos, CA, specializes in innovative cardiovascular therapeutics aimed at improving patient outcomes in heart disease. The company focuses on developing advanced steerable catheters and drug delivery systems that enhance cardiac treatments, particularly for conditions such as myocardial infarction. Biocardia's expertise extends to autologous cell therapies and endoluminal devices, leveraging cutting-edge technology to facilitate precise interventions and optimize therapeutic potency in cardiovascular care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

57 Patents

#5 in San Carlos, CA

#1,466 in California

#6,252 in US

#12,573 in the World

San Carlos, CA, United States of America

Biocardia, Inc.

Forward Citations = 4,674

35 inventors:

Peter A Altman (48 out of 62 patents)

Daniel C Rosenman (18 out of 38 patents)

Simon H Stertzer (11 out of 11 patents)

4. Daniel Jordan Kayser (10 out of 12 patents)

5. Wai Hsueh (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biocardia, Inc.. Retrieved from https://idiyas.com/company/biocardia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…